Divi's Laboratories Limited — Financials & Forensics
Sector: Healthcare · NSE: DIVISLAB · BSE: 532488 · ISIN: INE361B01024
18 Aug 2026
Add DIVISLAB to your watchlist — all of this, automated.
Sign in with GoogleAnnual P&L snapshot
| Line item | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue from operations | ₹8,960 Cr | ₹7,768 Cr | ₹7,845 Cr | ₹9,360 Cr | ₹10,560 Cr |
| EBITDA | ₹3,882 Cr | ₹2,368 Cr | ₹2,205 Cr | ₹2,968 Cr | ₹3,441 Cr |
| EBITDA margin | 43.3% | 30.5% | 28.1% | 31.7% | 32.6% |
| Profit after tax | ₹2,960 Cr | ₹1,823 Cr | ₹1,600 Cr | ₹2,191 Cr | ₹2,568 Cr |
Deeper analysis
Recent filings by Divi's Laboratories Limited
-
Outcome of 36th AGM - submission of AGM proceedings, voting results and Scrutinizer''s report.
10 Aug 2026 · General Update
-
Submission of transcript of Earnings Conference Call held on August 01, 2026
06 Aug 2026 · Financial Results
-
Newspaper clippings regarding unaudited financial results of the Company for the quarter ended June
03 Aug 2026 · Regulatory Compliance
-
Analysts/Institutional Investor Meet/Con. Call Updates
01 Aug 2026 · General Update
-
As per enclosed letter.
01 Aug 2026 · Financial Results
Never miss a filing again
About Divi's Laboratories Limited on Indian Stock Alerts
Indian Stock Alerts tracks Divi's Laboratories Limited's SEBI / exchange filings in real time. Every quarterly result, audited annual report, shareholding pattern update, insider trade and corporate announcement is automatically parsed and surfaced as a structured data point — with a link back to the underlying filing.
Data points refreshed daily include closing price, 1Y change, market cap, P/E, ROE, dividend yield, RPT volume, audit / governance / accrual flags. Quarterly results numbers refresh within minutes of the company filing them with BSE / NSE.